Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Intangibles (2009 - 2026)

Charles River Laboratories International (CRL) posted Intangibles of $253.2 million for Q2 2026, up 1.68% on a QoQ basis from $249.0 million in Q1 2026, and down 57.98% year-over-year from $602.5 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Intangibles (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Intangibles for 18 years, with the latest figure at $253.2 million in Q2 2026.

  • On a quarterly basis, Intangibles fell 57.98% year-over-year to $253.2 million in Q2 2026; TTM through Jun 2026 was $253.2 million, a 57.98% decrease from a year earlier, with the FY2025 full-year figure at $340.0 million, down 53.0% from the prior year.
  • Intangibles was $253.2 million for Q2 2026 at Charles River Laboratories International, up from $249.0 million in the prior quarter.
  • The five-year high for Intangibles was $1.0 billion in Q2 2022, with the low at $249.0 million in Q1 2026.
  • Average Intangibles over 5 years is $745.3 million, with a median of $813.9 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Intangibles increased 28.15% in 2022, then tumbled 62.03% in 2026.
  • Over 5 years, Intangibles stood at $955.3 million in 2022, then dropped by 9.55% to $864.1 million in 2023, then slipped by 16.28% to $723.4 million in 2024, then plunged by 53.0% to $340.0 million in 2025, then retreated by 25.54% to $253.2 million in 2026.
  • The last three Intangibles figures came in at $253.2 million (Q2 2026), $249.0 million (Q1 2026), and $340.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 4.75 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 33.11 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 3.15 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 253.17 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 586.80 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 44.39 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 5.12 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 253.17 Mn
Mar 28, 2026 248.99 Mn
Dec 27, 2025 340.00 Mn
Sep 27, 2025 571.09 Mn
Jun 28, 2025 602.45 Mn
Mar 29, 2025 655.71 Mn
Dec 28, 2024 723.40 Mn
Sep 28, 2024 778.46 Mn
Jun 29, 2024 800.13 Mn
Mar 30, 2024 827.64 Mn
Dec 30, 2023 864.05 Mn
Sep 30, 2023 886.29 Mn
Jul 1, 2023 929.89 Mn
Apr 1, 2023 958.12 Mn
Dec 31, 2022 955.28 Mn
Sep 24, 2022 968.02 Mn
Jun 25, 2022 1.03 Bn
Mar 26, 2022 1.02 Bn
Dec 25, 2021 1.06 Bn
Sep 25, 2021 1.10 Bn